Question 1

Is Olanzapine-Pamoate-Monohydrate currently in shortage?

Accepted Answer

Yes. As of the latest regulator updates, Olanzapine-Pamoate-Monohydrate has 46 active shortage notices across 10 countries (Belgium, New Zealand, Australia, European Union, Canada, Ireland and more). Status is refreshed daily from official regulatory sources.

Question 2

Why is Olanzapine-Pamoate-Monohydrate in shortage?

Accepted Answer

Regulators attribute the current Olanzapine-Pamoate-Monohydrate shortages to causes not stated by the regulator, supply-chain disruption, manufacturing problems. The exact cause varies by country and product — each notice on this page links to the official source.

Question 3

When will the Olanzapine-Pamoate-Monohydrate shortage be resolved?

Accepted Answer

Regulator-estimated resolution dates currently range from 30 Nov 2025 to 31 Dec 2026, depending on country and product. These estimates come from the manufacturers via regulators and often change — check the per-country table above for the latest.

Question 4

Where does this Olanzapine-Pamoate-Monohydrate shortage data come from?

Accepted Answer

Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ official regulators across 35+ countries and never publishes unsourced shortage claims.

Country	Severity	Notices	Since	Est. resolution	Source
Belgium	high	12	19 Jun 2024	30 Sept 2026	FAMHP
New Zealand	high	5	15 Jan 2026	—	Pharmac

Olanzapine-Pamoate-Monohydrate shortage status

Where Olanzapine-Pamoate-Monohydrate is in shortage

Why Olanzapine-Pamoate-Monohydrate is in shortage

Recent shortage history

Frequently asked questions

Get alerted when Olanzapine-Pamoate-Monohydrate status changes